Back to Search Start Over

Second neoplasm in children treated in EORTC 58881 trial for acute lymphoblastic malignancies: low incidence of CNS tumours.

Authors :
Renard, Marleen
Suciu, Stefan
Bertrand, Yves
Uyttebroeck, Anne
Ferster, Alina
van der Werff Ten Bosch, Jutte
Mazingue, F
Plouvier, Emmanuel
Robert, Alain
Boutard, Patrick
Millot, Frédéric
Munzer, Martine
Mechinaud, F
Lescoeur, Brigitte
Baila, L.
Vandecruys, Els
Benoît, Yves
Philippet, Pierre
EORTC Children Leukaemia Group (CLG)
Renard, Marleen
Suciu, Stefan
Bertrand, Yves
Uyttebroeck, Anne
Ferster, Alina
van der Werff Ten Bosch, Jutte
Mazingue, F
Plouvier, Emmanuel
Robert, Alain
Boutard, Patrick
Millot, Frédéric
Munzer, Martine
Mechinaud, F
Lescoeur, Brigitte
Baila, L.
Vandecruys, Els
Benoît, Yves
Philippet, Pierre
EORTC Children Leukaemia Group (CLG)
Source :
Pediatric blood & cancer, 57 (1
Publication Year :
2011

Abstract

Intensive chemotherapy has markedly improved the survival of children with acute lymphoblastic leukaemia (ALL) or lymphoblastic lymphoma (LL). Evaluation of late effects and analysis of factors contributing to their occurrence has become of major importance. Second neoplasm (SN) belongs to the most severe late events.<br />Comparative Study<br />Journal Article<br />Multicenter Study<br />Research Support, N.I.H. Extramural<br />Research Support, Non-U.S. Gov't<br />FLWIN<br />SCOPUS: ar.j<br />info:eu-repo/semantics/published

Details

Database :
OAIster
Journal :
Pediatric blood & cancer, 57 (1
Notes :
1 full-text file(s): application/pdf, English
Publication Type :
Electronic Resource
Accession number :
edsoai.ocn803463420
Document Type :
Electronic Resource